Brief: Compugen To Receive $10 Mln Milestone Payment
08/01/2024 14:12
Jan 8 (Reuters) - AstraZeneca PLC AZN.L :
* COMPUGEN TO RECEIVE $10 MILLION MILESTONE PAYMENT
FOLLOWING
DOSING OF FIRST PATIENT IN ASTRAZENECA PHASE 3 RILVEGOSTOMIG
TRIAL IN BILIARY TRACT CANCER
Source text for Eikon: ID:nPn9SPghMa
Further company coverage: AZN.L
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Compugen
See all newsIsrael's Compugen Q2 revenue more than doubles, net loss narrows
Brief: Compugen Announces The Appointment Of Michele Holcomb, Ph.D., To Its Board Of Directors
Brief: Compugen Monetizes Portion Of Rilvegostomig Future Royalties To Astrazeneca For Up To $90 Million
Brief: Compugen Announces First Patient Dosed In Com701 Global Platform Trial In Platinum Sensitive Ovarian Cancer
Brief: Compugen Announces Leadership Transitions Effective September 2025